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 Systemic lupus erythematosus (SLE) is a chronic 
infl ammatory autoimmune disorder that aff ects 
various tissues, particularly the skin and kidney 
( 1, 2 ). Disease pathogenesis is characterized 
by the production of a range of autoantibodies, 
in particular antinuclear antibodies (ANA) ( 1 ). 
Treatment of SLE still relies on broad immuno-
suppressants, such as corticosteroids and hy-
droxychloroquine sulfates ( 3, 4 ). Although these 
treatments have been improved, they remain 
ineffi  cacious in some SLE patients, suggesting that 
alternative or unappreciated immune mechanisms 
may be operating. 
 Autoantibody-producing B cells appear cen-
tral to the pathogenesis of SLE. Many mechanisms 
have been proposed to explain their appear ance, 
from impaired survival/apoptosis signals prevent-
ing negative selection ( 5 ), to dysfunctional com-
plement or inhibitory Fc receptors ( 6, 7 ), to 
activation of Toll-like receptors (TLRs) in re-
sponse to accumulation of apoptotic bodies 
( 8, 9 ). However, substantial evidence indicates 
that T cells are important players in SLE ( 2, 10, 
11 ). Inhibition of T cell activation or T – B cell 
interaction is an eff ective way to prevent auto-
immunity in several animal models of SLE 
( 12, 13 ). More recently, mutation of the  Roquin 
gene, which specifi cally perturbs the function of 
follicular helper T cells, induces development of 
SLE in mice ( 14 ). In humans, various HLA hap-
lotypes have been associated with susceptibility 
to SLE ( 2, 10 ). T cell signaling in SLE patients 
can be abnormal, and analysis of anti-DNA 
autoantibodies has revealed somatic mutations, 
which are suggestive of T cell – dependent affi  n-
ity maturation ( 2, 10 ). B cell – depleting reagents, 
such as Rituximab, have shown promising ther-
apeutic effi  cacy in SLE clinical trials ( 15 ). It is still 
unclear whether this effi  cacy is caused by reduced 
autoantibody production or by the depletion of 
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 Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by 
the production of autoantibodies. However, the underlying cause of disease appears to 
relate to defects in T cell tolerance or T cell help to B cells. Transgenic (Tg) mice over-
expressing the cytokine B cell – activating factor of the tumor necrosis factor family (BAFF) 
develop an autoimmune disorder similar to SLE and show impaired B cell tolerance and 
altered T cell differentiation. We generated BAFF Tg mice that were completely defi cient 
in T cells, and, surprisingly, these mice developed an SLE-like disease indistinguishable 
from that of BAFF Tg mice. Autoimmunity in BAFF Tg mice did, however, require B cell –
 intrinsic signals through the Toll-like receptor (TLR) – associated signaling adaptor MyD88, 
which controlled the production of proinfl ammatory autoantibody isotypes. TLR7/9 acti-
vation strongly up-regulated expression of transmembrane activator and calcium modulator 
and cyclophilin ligand interactor (TACI), which is a receptor for BAFF involved in B cell 
responses to T cell – independent antigens. Moreover, BAFF enhanced TLR7/9 expression on 
B cells and TLR-mediated production of autoantibodies. Therefore, autoimmunity in BAFF 
Tg mice results from altered B cell tolerance, but requires TLR signaling and is independent 
of T cell help. It is possible that SLE patients with elevated levels of BAFF show a similar 
basis for disease. 
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aff ected ( Fig. 1 A ). Eff ector T cell expansion occurs before 
disease onset and depends on the presence of B cells ( 26 ). 
Therefore, we hypothesized that in BAFF Tg mice alteration 
of the B cell compartment leads to a change in the makeup 
of the T cell compartment and, combined, these changes con-
tribute to the development of high-affi  nity autoantibodies 
and, ultimately, autoimmune disease. Changes in T cells that 
might aff ect peripheral tolerance include inappropriate acti-
vation of autoreactive T cells, or impaired regulatory T cell 
(T reg cell) function. Unexpectedly, we found that the pro-
portion of T reg cells was signifi cantly elevated in the periph-
eral LNs (PLNs) of BAFF Tg mice ( Fig. 1 B ). Absolute 
numbers of T reg cells were increased in the spleen, PLN, 
and thymus, which is suggestive of a change in T reg cell 
production ( Fig. 1 C ). The consequence of increased numbers 
of eff ector and T reg cell numbers in BAFF Tg mice is un-
certain, but it does suggest a role of T cells in BAFF-mediated 
autoimmune disease. 
B cells with potent antigen-presenting cell (APC) function 
for T cells, or both. Despite the obvious pathogenic role of 
antibodies and B cells, the corruption of T cell tolerance has 
been considered an important underlying defect in antibody-
mediated systemic autoimmune diseases ( 2, 16 ). 
 B cell – activating factor of the TNF family (BAFF; also 
termed TNFSF13b and BLyS) is a TNF-like cytokine that is 
essential for the maturation and survival of peripheral B cells 
( 17, 18 ). BAFF transgenic (Tg) mice develop autoantibodies, 
leading to nephritis and salivary gland destruction, features 
that are reminiscent of SLE and Sj ö gren ’ s syndrome (SS), re-
spectively ( 19, 20 ). Elevated BAFF levels are detected in 
some human autoimmune conditions, including SLE ( 18, 20 ). 
Like most SLE mouse models, disease in BAFF Tg mice 
correlates with clear abnormalities of the B cell compartent, 
leading to inappropriate BAFF-induced survival of self-
reactive B cells ( 21 ). Moreover, we have shown that mar-
ginal zone (MZ) and B1 B cells may play tissue-specifi c roles 
in the pathogenesis of SLE in BAFF Tg mice ( 20, 22, 23 ). 
We have studied the eff ect of excess BAFF on B cell toler-
ance using hen egg lysozyme (HEL) B cell receptor (BCR) 
knock-in mice, combined with HEL/BAFF Tg mice. In this 
system, negative selection of self-reactive B cells was mostly 
normal, with expansion of only a subset of low-affi  nity, HEL-
specifi c B cells, with many of these being MZ B cells ( 24 ). 
Thus, the relevance of low-affi  nity, self-reactive B cells in 
BAFF-mediated autoimmunity is questionable, suggesting 
an additional pathogenic contribution from T cells and/or 
from innate immune signals. BAFF costimulates T cells and 
promotes T cell diff erentiation to eff ector cells ( 25 ), and in-
creased numbers of eff ector T cells are present in BAFF Tg 
mice ( 26 ). Therefore, we hypothesized that the BAFF Tg 
model is similar to many mouse models of SLE, with the 
likely combined involvement of both B and T cells in the 
disease process. 
 To determine the role of T cells in BAFF-driven auto-
immune disease, we crossed BAFF Tg mice onto mice lack-
ing both   /  and   /  T cells ( 27 ) and looked for signs of 
autoimmunity. Surprisingly, the resulting T-BTg mice 
were capable of producing proinfl ammatory autoantibodies 
and developed autoimmunity with the same severity as BAFF 
Tg mice. Although IgA autoantibody production was T cell 
dependent, it was dispensable for disease progression. We 
found that BAFF promoted TLR7/9 expression in B cells and 
TLR-induced production of autoantibodies, and that disease 
in BAFF Tg mice required B cell – intrinsic TLR-associated 
MyD88 signaling. Therefore, BAFF-induced SLE-like disease 
in BAFF Tg mice is a T cell – independent process, but re-
quires innate immune signals through MyD88 for B cell acti-
vation and production of pathogenic autoantibodies. 
 RESULTS 
 Altered T cell constitution in BAFF Tg mice 
 In BAFF Tg mice, total numbers of T cells are not changed ( 19 ), 
although there is an increased proportion of eff ector T cells 
( 19, 26 ). The CD8  T cell compartment is also signifi cantly 
 Figure 1.  T cell abnormalities in BAFF Tg mice. T cell subsets were 
determined by FACS, as described in the Materials and methods. (A) Total 
splenic T cell numbers of CD4  (top) and CD8  (bottom). Naive (left) 
or effector – memory (right) T cells were assessed from 12-mo-old WT 
(circle) and BAFF Tg (square) mice. (B) Representative FACS plots of PLN 
FoxP3  T reg cells from WT (left) and BAFF Tg (right) mice. The T reg cell 
population is indicated with a box. (C) Total numbers of T reg cells from 
WT (circle) and BAFF Tg (square) mice from thymus, spleen, and PLN. 
In A and C, symbols represent individual mice, and the mean for each 
group is indicated by a column. Signifi cant P values are shown.  n  7 
per group. 
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Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20062567/DC1). Splenomegaly, which is a typical feature 
of BAFF Tg mice, was unchanged in T-BTg mice ( Fig. 2 A ). 
Analysis of absolute numbers of transitional type 2 MZ (T2-MZ), 
T2 follicular (T2-Fo), MZ, and Fo B cells in the spleen, as well 
 Expansion of the B cell compartment in BAFF Tg mice 
is T cell independent 
 To address the role of T cells in the SLE disease seen in BAFF 
Tg mice, we crossed BAFF Tg mice onto TCR	/	 mice 
( 27 ) and generated BAFF Tg mice lacking T cells (T-BTg; 
 Figure 2.  Similar splenomegaly, B cell hyperplasia, and elevated Ig levels in T  -BTg and Baff Tg mice. 12-mo-old WT (circle), TCR 	/	 (diamond), 
BAFF Tg (square), and T  -BTg (triangle) mice were assessed for spleen size (A) and total numbers of T2-MZ, T2-Fo, MZ, and Fo B cell subsets in spleen and 
B1a, B1b, and Fo B cells in peritoneal lavage (PerC; B). (C) Fo and MZ B cells in peripheral blood (left) and PLN (right). Subsets were gated by FACS analysis 
as described in Materials and methods. (D) Basal Ig levels in T  -BTg mice and control mice. Symbols represent individual mice, and columns indicate the 
mean for each group. Signifi cant P values are shown.  n  7 per group. 
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However, similar to TCR 	/	 mice, affi  nity maturation was 
impaired in T-BTg mice, as tested by measuring antibody 
titers in a low-density, hapten-coated BSA ELISA (unpub-
lished data). 
 BAFF promotes isotype switching to IgA ( 29, 30 ), and 
BAFF Tg mice produce higher levels of IgA in response to 
both T cell – independent and  – dependent antigens ( Fig. 3, A 
and B ). T-BTg mice, in contrast, retained an IgA response 
to a T cell – independent antigen ( Fig. 3 A ), but not to the 
T cell – dependent antigen NP-OVA. Thus, in the absence of 
T cells, excess production of BAFF can allow partial class 
switching to Ig isotypes that are normally dependent on the 
presence of T cell help. In addition, BAFF-induced switch-
ing to IgA in response to T cell – dependent, but not T cell –
 independent, antigens relies on T cell help in vivo. 
 Production of IgA, but not IgG and IgM, autoantibodies 
is T cell dependent in BAFF Tg mice 
 Antibody reactivity with double-stranded (ds) DNA is associ-
ated with development of SLE ( 33, 34 ). Switching to IgG2a 
and IgG2b autoantibodies is linked to pathogenicity ( 35 – 37 ), 
whereas IgM anti-DNA antibodies, per se, are insuffi  cient for 
disease ( 38 ). Studies that have described a pathogenic role 
for IgG2a in C57BL/6 animal models ( 35 ) were most likely 
measuring IgG2c (an isotype recognized by most commercial 
anti-IgG2a reagents) because in C57BL/6 mice the  IgG2a 
gene is deleted ( 39 ). As T cells are thought necessary for 
development of the switched anti-DNA antibodies in SLE 
( 10, 34 ), we investigated whether T-BTg mice developed 
autoantibodies similar to those seen in BAFF Tg mice. Levels 
as B1a, B1b, and Fo B cells in the peritoneal cavity (PerC), B 
cell subsets that are particularly expanded in BAFF Tg mice 
( 21 ), revealed no diff erence between BAFF Tg and T  -BTg 
mice ( Fig. 2 B ). In BAFF Tg mice, a high proportion of MZ-
like B cells have been detected in the blood and PLNs ( 21 ), 
and we saw a similar expansion of this population in T  -BTg 
mice ( Fig. 2 C ). Levels of total serum IgG2c, IgG2b, IgG3, 
and IgM were increased similarly in T  -BTg mice, as in 
BAFF Tg mice ( Fig. 2 D ). IgG1 levels and, most importantly, 
IgA levels are elevated in BAFF Tg mice ( 28 ), possibly as a 
result of BAFF-induced isotype switching to IgA ( 29, 30 ). 
Interestingly, the levels of these two isotypes were normal in 
T-BTg mice ( Fig. 2 D ), suggesting a role for T cells in ad-
dition to that of BAFF in the augmentation of IgA and IgG1 
levels seen in BAFF Tg mice. Similarly, fecal IgA levels, 
which are elevated in BAFF Tg mice ( 19, 23 ), were normal 
in T-BTg mice (unpublished data). As expected, germinal 
centers were absent in T-BTg mice, which is similar to T 
cell – defi cient control mice (unpublished data). In conclu-
sion, expansion of the B cell compartment in BAFF Tg mice 
was T cell independent, resulting from a direct survival eff ect 
of BAFF on B cells, followed by B cell activation, whereas 
increased total serum IgG1 and IgA levels in BAFF Tg mice 
depended on T cell help. 
 Elevated IgG2c and IgG2b levels in T-BTg mice in response 
to T cell – dependent soluble antigen 
 BAFF promotes B cell activation ( 31 ) and BAFF Tg mice 
mount enhanced responses to immunization with both T 
cell – independent and  – dependent antigens ( 22, 23 ). BAFF is 
involved in isotype class switching, although this eff ect is of-
ten weak without additional T cell – dependent signals, such 
as CD40 ligand (CD40L) or T cell – derived cytokines ( 29, 30 ). 
Using our T-BTg mouse model, we addressed the contri-
bution of T cell help in BAFF-mediated isotype class switch-
ing in vivo. As expected, antibody responses to the T cell – 
independent antigen nitrophenyl (NP)-Ficoll is essentially similar 
in BAFF Tg and T-BTg mice, and increased compared with 
WT and TCR 	/	 mice, respectively ( Fig. 3 A ). The higher 
levels of NP-specifi c IgG1, IgG2c, and IgG2b seen in NP-
Ficoll – immunized BAFF Tg and T-BTg mice is intriguing 
because switching to these isotypes is characteristic of a re-
sponse to T cell – dependent antigens ( 32 ). 
 To test whether excess BAFF may, in part, help B cells 
overcome the need for the T cell – derived signals required for 
isotype switching, we tested the response of T-BTg mice to 
immunization with a soluble T cell – dependent antigen. The 
antibody response to the T cell – dependent soluble antigen 
NP-OVA given with adjuvant was impaired in T-BTg 
mice ( Fig. 3 B ). However, signifi cantly elevated levels of 
NP-specifi c IgG2c and IgG2b were detected in T-BTg 
mice compared with TCR 	/	 mice ( Fig. 3 B ), indicating 
that excess BAFF in T-BTg mice was able to partially sup-
port isotype switching to NP-specifi c IgG2c and IgG2b, 
a process that is normally dependent on the presence of 
T cells ( 32 ) and totally impaired in TCR 	/	 mice ( Fig. 3 B ). 
 Figure 3.  Increased switching to T cell – independent antigens and 
low-level switching to T cell – dependent antigens in T-BTg mice. 
Titers of antigen-specifi c Ig from 12-wk-old WT (circle), TCR 	/	 (diamond), 
BAFF Tg (square), and T-BTg (triangle) mice were determined, 5 d after 
T cell – independent NP-Ficoll immunization (A) and 28 d after initial 
T cell – dependent immunization NP-OVA (B). Symbols represent individual 
mice, and the mean for each group is indicated by a column.  n  5 per 
group. Signifi cant P values are shown between T-BTg v BAFF Tg and 
T-BTg v TCR 	/	 groups. 
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 T-BTg mice develop severe autoimmune features 
indistinguishable from those of BAFF Tg mice 
 As T-BTg mice are capable of producing autoantibodies of 
isotypes known to correlate with pathogenicity ( Fig. 4 ) ( 35, 37 ), 
we monitored these mice for features of autoimmunity and 
tissue destruction, as previously described for BAFF Tg mice 
( 19, 20 ). At 12 mo of age, similar elevated levels of proteinuria 
were detected in both BAFF Tg and T-BTg mice ( Fig. 5 A ), 
which is indicative of progressing nephritis. Histochemical 
staining of kidney sections from both BAFF Tg and T-BTg 
mice revealed nephritis, which is characterized by abnormally 
enlarged and segmented glomeruli and large infi ltrates of 
mononuclear cells ( Fig. 5 B ). Examination of Ig deposits in the 
kidneys of BAFF Tg mice revealed abundant IgM, IgA, and 
IgG deposits ( Fig. 5 C ). IgG deposits were predominantly 
IgG2c, IgG2b, and IgG3 (Fig. S3 A, available at http://www
.jem.org/cgi/content/full/jem.20062567/DC1). In contrast, 
kidneys from T-BTg mice contained IgM, IgG2c, and IgG2b 
deposits, but no IgG1 or IgA ( Fig. 5 C and Fig. S3 A). In 
addition, both BAFF Tg and T-BTg mice had deposits of 
C3 complement in glomeruli ( Fig. 5 D ), which is indicative 
of an ongoing infl ammatory process ( 41 ). Therefore, nephritis 
resulting from excessive BAFF production does not require 
T cells or deposits of IgA and IgG1 in the kidneys. 
 In BAFF Tg mice, sialadenitis correlates with the aberrant 
accumulation of MZ-like B cells in the salivary glands ( 20, 23 ). 
of IgM and IgG anti – single-stranded (ss) DNA, dsDNA, 
and rheumatoid factor (RF) autoantibodies were comparable 
in T-BTg and BAFF Tg mice ( Fig. 4 A ). Within the IgG rep-
ertoire, autoantibodies in T-BTg mice were predominantly 
IgG2c, IgG2b, and IgG3 isotypes (Fig. S2, A and B, available 
at http://www.jem.org/cgi/content/full/jem.20062567/DC1). 
IgA autoantibodies were not detected in T-BTg mice ( Fig. 
4 A ). Specifi cities of ANA and anti-dsDNA antibodies were 
further characterized using serum samples to stain slides car-
rying Hep-2 and  Crithidia luciliae , respectively ( Fig. 4 B ). This 
staining confi rmed the absence of IgA autoantibodies in T-
BTg mice, in contrast to BAFF Tg mice. The staining pattern 
of BAFF Tg – derived IgA autoantibodies on Hep-2 slides was 
granular and cytoplasmic, indicating reactivity to RNA com-
plexes ( Fig. 4 B ) ( 40 ). The staining pattern of all autoanti-
body isotypes from BAFF Tg mice on  C. luciliae slides was 
characteristic of kinetoplast staining, confi rming detection of 
dsDNA ( Fig. 4 B ). Although IgA autoantibody production 
was absent in T-BTg mice, the staining pattern observed 
with the remaining autoantibody isotypes was unchanged 
( Fig. 4 B ). Collectively, data in  Fig. 2 D and  Fig. 4 suggest 
that elevated production of IgA seen in BAFF Tg mice is 
not solely related to the role of BAFF in IgA class-switching 
( 29, 30 ), but also requires the presence of T cells. Never-
theless, activation of autoreactive B cells in BAFF Tg mice is 
a T cell – independent process. 
 Figure 4.  Production of IgM and IgG, but not IgA, autoantibodies in T-BTg mice. (A) ELISA was used to determine IgG, IgA, and IgM 
anti-ssDNA (top), anti-dsDNA (middle), and RF (bottom) in serum from 8-mo-old WT (circle), TCR 	/	 (diamond), BAFF Tg (square), and T-BTg (triangle) 
mice. Symbols represent individual mice, and the mean for each group is indicated by columns. Significant P values are shown.  n  6 per group. 
(B) Representative staining of isotype-specifi c ANA and anti-dsDNA were determined by staining Hep-2 and  C. luciliae slides, respectively, with serum 
from indicated mice. 
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T-BTg mice suff er from the same signs of infl ammation 
and tissue destruction ( Fig. 5 E ), which are characterized by 
decreased saliva production ( Fig. 5 F ), as was previously shown 
in BAFF Tg mice ( 20 ). Infi ltration of MZ-like B cells into the 
cervical LNs (CLNs) and salivary gland ( 20 ) was identical in 
both BAFF Tg and T-BTg mice ( Fig. 5 G ). IgA, IgM, and 
IgG deposition were also detected in the salivary gland of 
BAFF Tg mice, but only IgM and IgG deposits were detected 
in the same tissues from T-BTg mice ( Fig. 5 H ). IgG de-
posits were primarily IgG2c, IgG2b, and IgG3, with no IgG1 
seen in salivary glands from T-BTg mice (Fig. S3 B). Thus, 
BAFF Tg mice have severe autoimmune pathology that de-
velops independently of T cells, but concomitantly with pro-
duction and deposition of autoantibodies in aff ected tissues. 
 B cell activation and autoantibody production in BAFF Tg 
mice requires MyD88-dependent signaling 
 Because a severe autoimmune disease develops in T cell – 
defi cient BAFF Tg mice, alternative pathogenic mechanisms 
must be responsible for self-reactive B cell activation. We 
previously showed an expansion of the MZ and B1 B cell 
compartment in BAFF Tg mice ( 21, 23 ), and found the same 
for T-BTg mice ( Fig. 3 B ). MZ and B1 B cells are consid-
ered innate B cells with self-reactive properties, and they are 
particularly responsive to activation via TLRs ( 42 – 45 ). In ad-
dition, BAFF can enhance TLR-mediated B cell activation 
and Ig class switching in human B cells ( 45 ). Recent studies 
revealed that TLR7/9 may play a dominant role in SLE, 
although their role varies depending on the model under in-
vestigation ( 8, 46, 47 ). Using FACS-sorted, unswitched mouse 
B cells, we found that BAFF promoted TLR9-i nduced, but 
not TLR7-induced, isotype switching from IgM to IgG in vi-
tro (Fig. S4, A and B, available at http://www.jem.org/cgi/
content/full/jem.20062567/DC1). This may be a mechanism 
whereby BAFF specifi cally exacerbates self-reactive B cell 
activation via TLR9. 
 Stimulation of FACS-sorted WT Fo, MZ, B1a, and B1b 
B cells with TLR ligands showed that both TLR7 (R848) 
and TLR9 (CpG), but not TLR4 (LPS), activation led to a 
strong up-regulation of one of the three BAFF receptors, 
TACI, on Fo and MZ B cells ( Fig. 6 A ). TLR7/9 stimulation 
also increased TACI expression on B1 B cells, although TLR7 
activation was more potent than that of TLR9 ( Fig. 6 A ). 
TLR7/9 activation also led to up-regulation of the most widely 
expressed BAFF receptor (BAFF-R), although this was weaker 
and mostly restricted to Fo and MZ B cells ( Fig. 6 A ). These 
 Figure 5.  T-BTg and BAFF Tg mice develop indistinguishable 
kidney and salivary gland pathology. In A, F, and G, the mice are WT 
(circle), TCR  — / —  (diamond), BAFF Tg (square), and T-BTg (triangle). Sym-
bols represent individual mice, and the mean for each group is indicated 
by a column. (A) Proteinuria analysis of 12-mo-old animals. (B) HE staining 
of kidney tissue sections. BAFF Tg and T-BTg sections show glomeruli 
 separation (white arrows) and mononuclear cell infi ltrate (black arrows). 
(C) IgG, IgA, and IgM (D) C3 deposition in the kidney of 8-mo-old mice. 
(E) HE staining of salivary gland tissue sections from BAFF Tg and T-BTg 
sections show salivary gland destruction and lymphocyte infi ltrate (black 
arrows). (F) Saliva fl ow after pilocarpine injection in 8-mo-old animals. 
(G) Total numbers of MZ-like B cells detected in CLN and salivary glands. 
(H) Isotype-specifi c Ig deposition in salivary gland of 8-mo-old mice. 
 Signifi cant P values are shown. 
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results confi rm a recent independent study ( 48 ). Therefore, 
TLR7/9 activation in B cells strongly up-regulates the ex-
pression of TACI, a receptor that is essential for the response 
of B cells to T cell – independent antigens ( 49 ). Moreover, BAFF 
stimulation of sorted Fo, MZ, and B1 B cells in culture leads 
to a strong up-regulation of TLR7/9 expression on Fo and 
MZ, but not B1, B cells (Fig. S4 C). 
 Work by us and others demonstrated a role for MZ B 
cells in the pathogenesis of autoimmunity in BAFF Tg mice 
( 20, 23, 50 ). We sorted splenic Fo, MZ, and peritoneal B1 B 
cells from BAFF Tg mice and cultured these cells with vari-
ous TLR ligands, which were supplemented or not with ex-
ogenous recombinant BAFF, and measured total anti-dsDNA 
autoantibody levels in the supernatant. BAFF Tg – derived Fo 
B cells failed to produce anti-dsDNA autoantibodies under 
any of the conditions tested (unpublished data). Both BAFF 
Tg-derived MZ and B1 B cell populations contained auto-
antibody-producing cells in response to TLR stimulation 
( Fig. 6, B and C ). Activation of anti-DNA – producing, BAFF 
Tg – derived MZ and B1 B cells was increased in vitro in 
response to TLR4-, TLR9-, and TLR7-specifi c ligands. The 
addition of BAFF to these cultures further stimulated TLR9-
induced production of anti-dsDNA autoantibodies by both 
MZ and B1 B cell cultures ( Fig. 6, B and C ), and TLR2- and 
TLR3-induced autoantibody production in B1 B cell cul-
tures ( Fig. 6 C ). Thus, MZ and B1, but not Fo, B cells are the 
source of anti-dsDNA autoantibodies in BAFF Tg mice, and 
BAFF-enhanced autoantibody production occurs in response 
to stimulation through TLR9 in particular. Collectively, these 
results suggest cooperation between BAFF and TLR9 as the 
dominant driver of self-reactive MZ B cell activation in BAFF 
Tg mice. A more complex BAFF – TLR2/3/9 cooperation ex-
ists for B1 B cells. 
 Most TLRs, as well as receptors for IL-1 – related cytokines, 
recruit the signaling adaptor MyD88 upon activation ( 51 – 53 ). 
The BAFF transgene is liver-specifi c, allowing us to adop-
tively transfer BM from WT or MyD88 	/	 mice into lethally 
irradiated WT or BAFF Tg mice. 12 wk after reconstitution, 
a clear reduction in B cell activation was observed in BAFF 
Tg mice reconstituted with MyD88 	/	 BM compared with 
MyD88 / BM ( Fig. 7 A ). We also observed a loss of all 
autoreactive IgG isotypes ( Fig. 7 B ) and reduced IgM, but 
similar IgA, levels ( Fig. 7 B ), which is consistent with the T 
cell – dependent nature of autoreactive IgA production seen in 
T-BTg mice ( Fig. 2 D and Fig. 4 ). Total IgG2c and IgG2b 
levels in the blood of MyD88 	/	 BM – reconstituted mice 
were restored to normal, but IgA levels remained elevated 
(Fig. S5 B, available at http://www.jem.org/cgi/content/full/
jem.20062567/DC1). We examined Ig deposition in the 
kidneys of these animals and observed pronounced IgA and 
some IgM deposits, but no IgG, including the pathogenic 
IgG2c and IgG2b isotypes ( Fig. 7 C and Fig. S5 A). Interest-
ingly, lack of IgG deposition in the kidneys correlated with 
greatly reduced C3 deposition in the glomeruli and suggested 
an inhibition of complement-activated infl ammation in the 
kidneys ( Fig. 7 D ). Although IgM alone is not pathogenic ( 38 ), 
 Figure 6.  TLR7/9, but not TLR7, ligands increase BAFF-R expres-
sion, and BAFF enhances TLR-mediated autoantibody secretion. 
(A) FACS-sorted Fo, MZ, B1a, and B1b B cells were stimulated with the 
following: unstimulated (solid black), CpG (TLR9; dashed black), R848 (TLR7; 
solid gray), and LPS (TLR4; dashed gray) for 24 h and analyzed for surface 
expression of BAFF-Rs by FACS, as indicated. Histograms are representa-
tive of three individual sorting and culture experiments. MZ (B) and B1 (C) 
BAFF Tg B cells were cultured with TLR ligands with (squares) or without 
(circles) BAFF for 6 d. Total anti-dsDNA antibody levels in culture superna-
tants were measured by ELISA. Symbols indicate individual cultures. In 
C and D, signifi cant P values are shown between TLR-stimulated cultures 
with or without BAFF, between unstimulated and TLR stimulated (dashed 
line [x]) and between unstimulated with BAFF and TLR-stimulated with 
BAFF (solid line [y]). 
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the C3-fi xing ability of the remaining IgA deposits remains 
unclear. BAFF Tg mice reconstituted with MyD88 	/	 BM 
failed to develop proteinuria (unpublished data). In conclusion, 
MyD88-mediated signaling was essential for the production of 
autoantibodies of the IgG2c/b isotype, which were previously 
described as pathogenic in murine SLE ( 35, 37 ). 
 Two TLR-dependent mechanisms have been advanced 
to explain autoimmunity in SLE ( 8 ). The fi rst involves direct 
activation of TLRs in self-reactive B cells. The second in-
volves activation of TLRs in plasmacytoid DCs (pDCs), which 
in turn exacerbate autoimmune responses through produc-
tion of type I IFNs ( 8, 9 ). Numbers of splenic myeloid DCs 
(mDC) and pDCs were increased in BAFF Tg mice com-
pared with control mice (Fig. S5 C). However, these num-
bers correlated with the extent of splenomegaly (unpublished 
data). In addition, we saw no augmentation of mDC or pDC 
activation (expression of MHC class II and CD80) in BAFF 
Tg mice when compared with WT control cells (Fig. S5 C). 
The same observation was made for mDCs and pDCs in BAFF 
Tg mice reconstituted with MyD88 / or MyD88 	/	 BM 
(Fig. S5 D). We were also unable to detect IFN  in the se-
rum of all of these mice (unpublished data). The eff ector T cell 
compartment was not expanded in MyD88 	/	 - reconstituted 
BAFF Tg mice (Fig. S5 E), suggesting that this eff ect was not 
merely B cell – dependent ( 26 ), but also dependent on MyD88 
signaling in B cells. BAFF production was not impaired in 
MyD88 	/	 mice; in fact, BAFF levels were slightly elevated in 
the serum of these mice compared with WT animals (Fig. S4 D). 
This result is consistent with the elevated expression of CD23 
seen on MyD88 	/	 B cells ( 54 ), a molecule known to require 
BAFF for its expression ( 55 ). 
 Lack of MyD88 can aff ect the function of innate cells in 
addition to that of B cells. To address this point, we reconsti-
tuted irradiated BAFF Tg mice with a 50:50 mix of MyD88 	/	 
and Rag1 	/	 BM to repopulate the immune system of recipient 
BAFF Tg mice with MyD88-suffi  cient innate cells in the pres-
ence of MyD88 	/	 B cells. Macrophages derived from the BM 
of animals reconstituted with the Rag1 	/	 /MyD88 	/	 BM 
mix, but not those derived from MyD88 	/	 -reconstituted 
BAFF Tg mice, produced TNF in response to LPS ex vivo (un-
published data), confi rming development of these cells from the 
Rag1 	/	 BM source. Animals recon stituted with the Rag1 	/	 /
MyD88 	/	 BM mix had slightly more IgG autoantibodies in 
the serum than MyD88 	/	 BM – reconstituted mice ( Fig. 7 B ). 
 Figure 7.  MyD88 signaling is essential for B cell activation and 
IgG autoantibody production in BAFF Tg mice. Lethally irradiated 
6-wk-old BAFF Tg mice were reconstituted with MyD88/ or MyD88	/	 or 
mixed Rag1	/	MyD88/ or Rag1	/	MyD88	/	 BM, as indicated. (A) Histo-
gram of B cell activation markers CD44 (top) and CD69 (bottom) of Fo (left) 
and MZ (right) splenic B cells from MyD88/ (solid line) and MyD88	/	 
(dashed line) BAFF Tg BM chimeras. (B) Anti-dsDNA and RF antibody 
production in WT mice reconstituted with MyD88/ (circles) or MyD88	/	 
(diamonds); BAFF Tg mice reconstituted with MyD88/ (squares; light 
gray bar); or MyD88	/	 (triangles; light gray bar); or BAFF Tg mice recon-
stituted with Rag1	/	MyD88/ (squares; dark gray bar); or Rag1	/	
MyD88	/	 (triangles; dark gray bar). IgG, IgA, and IgM (C) and C3 (D) 
deposition in the kidney of BAFF Tg mice reconstituted with MyD88/, 
MyD88	/	, Rag1	/	MyD88/, or Rag1	/	MyD88	/	 BM, as indicated. 
Signifi cant P values are shown. 
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of B cells to IgA in a T cell – dependent and  – independent 
fashion, particularly in MZ and B1 B cells, which are two 
expanded B cell subsets in BAFF Tg mice ( 18, 59 ). However, 
this eff ect is potentiated by the addition of T cell – derived 
factors, such as CD40L and IL-4 ( 29, 59 ). Therefore, it is 
likely that high IgA levels in BAFF Tg mice are the result of 
BAFF-induced switching to IgA potentiated by endogenous 
T cell – derived factors. It is important to note that although 
serum IgA levels are reduced in T-BTg mice compared with 
BAFF Tg mice, these levels are normal compared with WT 
animals, supporting the notion that T cell – dependent, but not 
T cell – independent, production of IgA is exacerbated by ex-
cess BAFF production. Switching to IgG2c and IgG2b in re-
sponse to T cell – dependent antigens occurs at low levels in 
T-BTg mice. BAFF combined with IL-21 can stimulate 
switching of B cells to IgG as effi  ciently as T cell – dependent 
signals, such as CD40L or IL-4 ( 60 ). Therefore, it is possible that 
excess BAFF in the presence of other endogenous cytokines, 
such as IL-21, may provide T cell – like signals, driving low 
levels of switching to IgG2c and IgG2b in T cell – defi cient 
BAFF Tg mice. 
 In view of the emerging role of TLR7/9 in SLE ( 8, 9, 
57 ), TLR signaling was a candidate mechanism for disease 
progression in BAFF Tg mice. MZ and B1 B cells are often 
referred to as  “ innate ” B cells and are particularly responsive 
to TLR activation ( 42 – 44 ). We showed that BAFF stimula-
tion of Fo and MZ, but not B1, B cells strongly up-regulated 
TLR7/9 expression. In turn, activation of TLR7/9, but not 
of TLR4, strongly up-regulated TACI expression on B cells. 
TACI is a receptor for BAFF that is essential for B cell re-
sponses to T cell – independent antigens ( 49 ). Thus, a tight 
connection between TACI expression and TLR activation 
may be a central pathogenic mechanism in BAFF Tg mice 
( Fig. 8 ). In fact, TACI may play a role in the production of 
anti-chromatin autoantibodies ( 61 ). 
 TLR9-mediated promotion of autoantibodies was exac-
erbated by BAFF in both BAFF Tg – derived MZ and B1 
B cells. However, reconstitution of BAFF Tg mice with 
TLR9 	/	 BM did not prevent the production of IgG auto-
antibodies and kidney infl ammation. As TLR7 activation has 
similar eff ects to TLR9 on TACI expression, it is possible 
that ablation of TLR9 has been compensated for by TLR7 
activation. TLR9 is involved in the pathology of several, but 
not all, mouse models of SLE ( 50, 62 ). For instance, in the 
MRL-lpr model, TLR9 has a protective role, and defi ciency 
in TLR9 exacerbates SLE ( 47 ). This protection may occur, 
in part, via enhanced IL-10 production from TLR9-activated 
MZ B cells ( 44, 63 ), a population that is also expanded in 
MRL-lpr mice ( 64 ). In MRL-lpr mice lacking BAFF-R sig-
naling, aspects of nephritis were more severe ( 65 ). Whether this 
eff ect is linked to lack of MZ B cells in these mice is unclear. 
 In contrast to TLR9, TLR7 defi ciency has a protective 
eff ect in the MRL-lpr model ( 46, 47 ). Yet, there is a major dif-
ference between this model and BAFF Tg mice. The MRL-
lpr model is T cell dependent ( 12 ), whereas SLE in BAFF 
Tg mice, shown here, is not. In support of this diff erence, 
This suggests that MyD88 expression in innate cells plays 
some role in autoantibody production. However, similar to 
MyD88 	/	 BM-reconstituted mice, animals reconstituted 
with the Rag1 	/	 /MyD88 	/	 BM mix did not show any 
IgG deposition or C3 fi xation in the kidney ( Fig. 7, C and D ). 
Thus, MyD88 expression in B cells is likely an important 
element contributing to the pathogenic role of B cells in 
BAFF Tg mice. 
 Our in vitro work implicated a role for TLR9 and BAFF 
in autoantibody production. To address this point, irradiated 
BAFF Tg mice were reconstituted with TLR9 	/	 or control 
TLR9 / BM. However, we observed no protection or dif-
ferences in autoantibody production (Fig. S6, available at 
http://www.jem.org/cgi/content/full/jem.20062567/DC1), 
or signs of kidney infl ammation (unpublished data), suggesting 
that disease in BAFF Tg mice does not rely solely on TLR9 
signaling. In view of the equally important role of TLR7 in 
our system ( Fig. 6 A ), extensive genetic approaches will need 
to be used to fully dissect TLR signaling in this system. 
 In conclusion, there was no evidence of mDC or pDC 
dysregulation in BAFF Tg mice; rather, lack of MyD88-
mediated signaling directly aff ected B cell function, preventing 
pathogenic autoantibody-mediated kidney disease and eff ector 
T cell expansion. 
 DISCUSSION 
 Various mechanisms have been suggested as drivers of SLE. 
These include dysregulation of the innate immune system, 
overproduction of infl ammatory cytokines, and impaired B 
and T cell tolerance/regulation ( 2, 4, 56 ). These mechanisms 
may be linked. For instance, accumulation of apoptotic cell –
 derived nucleic acids can lead to TLR-dependent activation 
of pDCs, production of type I IFNs, which stimulate DC 
maturation and self-reactive T and B cell activation ( 8, 9, 57 ). 
In addition, the activity of B cells as APCs for T cells may be 
important in corrupting immune tolerance in SLE ( 58 ). Finally, 
the pathology in SLE appears closely linked to the costimula-
tory role of self-reactive T cells ( 10, 14, 16 ). This model sug-
gests a complex conspiracy between innate immunity, T cells, 
and B cells in SLE, and that disarming one contributor should 
infl uence disease pathogenesis. For instance, the B cell –
 depleting mAb Rituximab ameliorates disease in many patients 
with SLE ( 15 ) and underscores the importance of B cells, 
either as initiators or as end-stage eff ectors, in the pathogenesis 
of human SLE. 
 In this study, we showed that overexpression of BAFF in 
mice led to the development of a T cell – independent form 
of SLE. This was a surprising result because the initial analysis 
of BAFF Tg mice was consistent with the accepted idea of T 
and B cell involvement in SLE, with excessive autoantibody 
production ( 19 ) and an expanded eff ector T cell compartment 
( 19, 26 ). These results are supported by other studies that 
showed that CD40 and germinal center formation were not 
required for disease in BAFF Tg mice ( 22, 23, 50 ). 
 Although disease in BAFF Tg mice was T cell independent, 
T cells did augment IgA levels. BAFF can induce switching 
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either, as it promotes Th2 cytokine release ( 53 ), whereas BAFF 
has been shown to oppose it ( 26 ). IL-1 can costimulate B 
cell activation ( 67 ) and plays an important proinfl ammatory 
role in SLE ( 68 ). Therefore, an IL-1 – mediated proinfl am-
matory role in the glomerulonephritis of BAFF Tg mice 
is not excluded. 
 An intriguing question is how SLE-like disease is triggered 
in BAFF Tg mice. Cell death is an ongoing process in healthy 
individuals as part of cellular turnover, immune tolerance, and 
regulation, and also occurs as a result of infections. Therefore, 
cell-derived nuclear autoantigens are continuously present. In 
BAFF Tg mice, three events lead to autoimmunity: (a) failure 
of B cell tolerance during splenic maturation and accumula-
tion of self-reactive B cells ( 24 ), (b) up-regulation of TLR ex-
pression in B cells, and (c) MyD88-dependent B cell activation 
in the presence of high BAFF levels, promoting production of 
proinfl ammatory autoantibodies ( Fig. 8 ). The production of 
IgG2a/c and IgG2b autoantibody isotypes is linked to kidney 
disease in our SLE model and others ( 35, 36 ), and their pro-
duction requires MyD88 in BAFF Tg mice. 
 Understanding the exact role of individual TLRs in 
mouse SLE is very much dependent on the SLE model under 
investigation. Of the many known mouse SLE models, the 
MRL-lpr, the  Yaa , and the  Roquin models have an important 
T cell component driving disease ( 14, 69 ), and in the fi rst 
two models, TLR7, which stimulates IFN  production by 
pDC, exacerbates T/B cell responses ( 47 ). In contrast, in 
Fc  RIIB 	/	 mice or mice expressing the Ly108.1 isoform, 
and in BAFF Tg mice, disease is linked directly to impaired 
B cell tolerance ( 38, 70 ). Of the B cell – dependent SLE 
models, BAFF Tg mice are unique because self-reactive B cells 
are selected into the MZ B cell compartment ( 21, 24 ) and, 
possibly, the B1 B cell pools, both of which are particularly 
responsive to TLR activation, especially in the presence of 
BAFF ( 43, 44, 63 ). 
 Our results describe a new mechanism leading to SLE-
like disease in mice, and highlight the diversity of separate 
disorders that can, by themselves, generate the same SLE-like 
syndrome. It will be a challenge to identify the various forms 
of SLE in humans, and whether they are T or B cell domi-
nant, to allow new diagnostic approaches that are likely to 
help stratify SLE patients into groups with predictable re-
sponses to diff erent therapies. A logical extension of these 
fi ndings is to investigate whether human SLE patients with 
high serum BAFF levels have a similar MyD88-dependent 
and T cell – independent form of disease. 
 MATERIALS AND METHODS 
 Mice.  BAFF Tg mice on a C57BL/6 background have been previously 
described ( 19 ). Mice homozygous for both the TCR  tm/Mom and the 
TCR  tm/Mom -targeted mutations on a C57BL/6 background were purchased 
from The Jackson Laboratory ( 27 ). BAFF Tg x    TCR 	/	 (T-BTg) mice 
were generated by breeding homozygous BAFF Tg and    TCR 	/	 mice 
and F1 interbreeding. Experimental animals were double-homozygous for 
the BAFF transgene and the    TCR 	/	 mutation. The BAFF transgene was 
determined using PCR and Southern blot assays on genomic tail snip DNA, 
as previously described ( 21 ).    TCR 	/	 status was determined by FACS 
MRL-lpr mice crossed onto BAFF-R mutant mice show 
impaired B cell development, but develop SLE ( 65 ). In the 
MRL-lpr SLE model, the pathogenic mechanism through 
TLR7 is linked to its role in T cell activation ( 47 ). In BAFF 
Tg mice, we showed that pDC activation was not altered 
and that IFN  production was undetectable, leaving pDC 
involvement as an unlikely mechanism for potentiating the 
autoimmune process. We did not see an alteration of other 
immune cells, such as NK cells or granulocytes, in BAFF Tg 
mice (unpublished data). Interestingly, we have reported that 
B1 B cells are particularly associated with nephritis in BAFF 
Tg mice ( 23 ), and our results here showed that TLR7 acti-
vation, more than TLR9, up-regulated TACI expression on 
B1 B cells. Therefore, it is possible that TLR7 may play a more 
dominant pathogenic role in the BAFF Tg model of nephri-
tis, via the promotion of TACI-dependent responses by 
autoreactive B cells to T cell – independent signals. Generating 
mice with multiple TLR mutations will be needed to address 
this point. 
 We confi rmed the importance of TLR-associated 
MyD88-dependent signaling in driving B cell activation in 
BAFF Tg mice, using MyD88 	/	 BM – reconstituted BAFF 
Tg mice in which B cell activation, secretion of pathogenic 
autoantibody isotypes, and C3 fi xation in the kidneys were 
all reduced. We also showed that MyD88 expression in B 
cells is important to drive kidney disease in BAFF Tg mice. 
The MyD88 adaptor is also recruited by receptors of IL-1, 
-18, and -33 ( 52, 53 ). We have no evidence that expression 
of these cytokines is abnormal in BAFF Tg mice (unpub-
lished data). The biology of IL-18 and its role in SLE is 
strongly associated with activation of Th1 T cells ( 66 ), and as 
disease in BAFF Tg mice is clearly T cell independent, IL-18 
production is an unlikely link. IL-33 is not a likely candidate 
 Figure 8.  Model of BAFF-induced, T cell – independent auto-
immune disease. (Stage 1) Excess levels of BAFF expand self-reactive MZ 
and B1 B cells ( 24 ). (Stage 2) BAFF signals promote TLR activation after 
internalization of autoreactive B cell receptors bound to either dsDNA or 
to immune complexes containing nucleic acids. (Stage 3) Positive feed-
back of this activation exists, with BAFF increasing TLR7/9 expression and 
TLR7/9 ligands stimulating BAFF-R expression. (Stage 4) BAFF enhances 
TLR signals, which lead to the production of IgG2c and IgG2b antibodies. 
Autoantibodies deposit in the kidney and promote infl ammation through 
complement fi xation. 
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for ANA or anti-dsDNA antibody detection, respectively. FITC anti – mouse 
Ig (BD Biosciences) was used to detect mouse antibodies. Slides were ana-
lyzed by fl uorescent microscopy (Leica) at 128
 magnifi cation. 
 Organ pathology.  Kidneys and salivary glands were fi xed with 4% parafor-
maldehyde in PBS and embedded in paraffi  n. 4   m paraffi  n-embedded sec-
tions were dewaxed and stained with hematoxylin and eosin (HE). For Ig 
and complement C3 deposition, tissues were snap frozen embedded in 
Tissue-Teck OCT compound (Sakura). 5-  m sections were fi xed with acetone 
and blocked with 5   g/ml purifi ed rat anti – mouse CD16/CD32 (BD Bio-
sciences) and 5   g/ml polyclonal human IgG (Biogen-Idec) in PBS for 
10 min before staining with FITC-conjugated anti – mouse Ig isotypes (BD 
Biosciences) or FITC-conjugated anti – mouse C3 (Cedarlane Laboratories). 
 TLR stimulation.  TLR ligands used were as follows: 1   g/ml peptidogly-
can (stimulating TLR2); 1   g/ml polyinosinic-polycytidylic acid (poly[I:C]; 
TLR3); 0.25   g/ml LPS (TLR4); 0.5   g/ml R848 (TLR7); and the CpG 
sequences ODN 1826 (0.5   g/ml) and ODN 2216 (1   g/ml; CpGB and 
CpGA, respectively; TLR9; InvivoGen). 1   g/ml of recombinant murine 
BAFF (Apotech) was added or not with TLR ligands in B cell cultures. MZ 
(B220  CD23 	 CD21 h i) B cells and peritoneal B1a (CD5  B220 int ) and B1b 
(CD5  B220 int ) B cells were sorted using a FACSAria (BD Biosciences). 
 Statistical analysis.  Statistical signifi cance was determined using a Student ’ s 
 t test. Values are shown for data that reached a signifi cance of P  0.05. 
 Online supplemental material.  Fig. S1 confi rms lack of T cells in the 
T-BTg mouse line. Fig. S2 shows autoreactive IgG subclasses produced in 
T-BTg mice. Fig. S3 shows IgG subclass deposition in kidneys and salivary 
glands of BAFF Tg and T-BTg mice. Fig. S4 shows that BAFF enhanced 
TLR-mediated IgG switching, increased TLR7/9 mRNA expression in Fo and 
MZ, but not B1, B cells after BAFF stimulation, and increased levels of BAFF 
in the serum of MyD88 	/	 mice. Fig. S5 shows MyD88 / and MyD88 	/	 
BAFF Tg BM chimeras and the DC phenotype in BAFF Tg mice. Fig. S6 
shows that anti-dsDNA antibody production is similar in BAFF Tg mice re-
constituted with TLR9 / or TLR9 	/	 BM. The online version of this article 
is available at http://www.jem.org/cgi/content/full/jem.20062567/DC1. 
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